Liminal Biosciences (NASDAQ:LMNL) will report on Q4 2022.
Intuit Shares Quiet, Federal Trade Commission Releases Case Report Alleging Co.’s Advertisements Mislead Consumers
https://www.ftc.gov/legal-library/browse/cases-proceedings/192-3119-intuit-inc-matter-turbotax